Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells

被引:36
作者
Pirillo, Angela [1 ]
Reduzzi, Alice [1 ]
Ferri, Nicola [1 ]
Kuhn, Hartmut [2 ]
Corsini, Alberto [1 ]
Catapano, Alberico L. [1 ,3 ]
机构
[1] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy
[2] Charite, Inst Biochem, D-13353 Berlin, Germany
[3] IRCCS Multimed Milan, Milan, Italy
关键词
LOX-1; LDL; 15-Lipoxygenase; Endothelial cells; ICAM-1; INDUCED INFLAMMATORY RESPONSE; HUMAN ATHEROSCLEROTIC LESIONS; VASCULAR ENDOTHELIUM; SCAVENGER RECEPTORS; MONOCYTE ADHESION; DEFICIENT MICE; MESSENGER-RNA; KAPPA-B; OX-LDL; EXPRESSION;
D O I
10.1016/j.atherosclerosis.2010.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Lectin-like oxidized LDL receptor-1 (LOX-1), the endothelial receptor for OxLDL, is believed to be responsible for a number of OxLDL-induced effects in the endothelium. Methods and results: In the present study we showed that LDL modified by 15-lipoxygenase (15LO-LDL), a form of minimally modified lipoprotein, beside its ability to induce pro-inflammatory responses such as oxidative stress and the expression of adhesion molecules, significantly increases LOX-1 expression in endothelial cells, both at transcriptional and at protein level. Such effect is likely to be mediated by p38 MAPK and NF-kB pathways. We then permanently overexpressed LOX-1 in an endothelial cell line and showed that 15LO-LDL were a ligand for LOX-1, and that the interaction LOX-1/15LO-LDL upregulated ICAM-1 surface expression. Conclusion: Altogether these results indicate minimally modified LDL as a new inducer for LOX-1 expression and as a new ligand for LOX-1. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 41 条
  • [11] The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease
    Dunn, Sarah
    Vohra, Ravinder S.
    Murphy, Jane E.
    Homer-Vanniasinkam, Shervanthi
    Walker, John H.
    Ponnambalam, Sreenivasan
    [J]. BIOCHEMICAL JOURNAL, 2008, 409 : 349 - 355
  • [12] PERMANENT CELL-LINE EXPRESSING HUMAN FACTOR-VIII-RELATED ANTIGEN ESTABLISHED BY HYBRIDIZATION
    EDGELL, CJ
    MCDONALD, CC
    GRAHAM, JB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3734 - 3737
  • [13] Is there a role for 15-lipoxygenase in atherogenesis?
    Feinmark, SJ
    Cornicelli, JA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (09) : 953 - 959
  • [14] Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116
  • [15] Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors
    Garton, KJ
    Ferri, N
    Raines, EW
    [J]. BIOTECHNIQUES, 2002, 32 (04) : 830 - +
  • [16] Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice
    Harats, D
    Shaish, A
    George, J
    Mulkins, M
    Kurihara, H
    Levkovitz, H
    Sigal, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) : 2100 - 2105
  • [17] DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
    HAVEL, RJ
    EDER, HA
    BRAGDON, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) : 1345 - 1353
  • [18] Statins and foam cell formation: Impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors
    Hofnagel, Oliver
    Luechtenborg, Birgit
    Weissen-Plenz, Gabriele
    Robenek, Horst
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2007, 1771 (09): : 1117 - 1124
  • [19] High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1)
    Hoshikawa, H
    Sawamura, T
    Kakutani, M
    Aoyama, T
    Nakamura, T
    Masaki, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (03) : 841 - 846
  • [20] Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice
    Huo, YQ
    Zhao, L
    Hyman, MC
    Shashkin, P
    Harry, BL
    Burcin, T
    Forlow, SB
    Stark, MA
    Smith, DF
    Clarke, S
    Srinivasan, S
    Hedrick, CC
    Praticò, D
    Witztum, JL
    Nadler, JL
    Funk, CD
    Ley, K
    [J]. CIRCULATION, 2004, 110 (14) : 2024 - 2031